PharmAla and Mindset enter psilocybin distribution agreement

Mugglehead
By Rowan DunneNov 16, 2022, 6:32 pm236 pts
PharmAla Biotech (CSE:MDMA) will no longer be solely focused on the production and distribution of MDMA, thanks to a new agreement with Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF). On Wednesday, the companies announced a new sales agreement which will allow PharmAla to resell cGMP psilocybin…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Federal Bill Would ‘Effectively’ Ban All Consumable Hemp Products—’Including CBD’—Congressional Researchers Say 67

Knocking Over the Glasses 64

Texas Hemp Advocates Nearing 150,000 Signatures Urging Gov. Abbott to Veto SB 3 64

The Very Large and Vexing Lawsuit Re: Cannabinoid Hyperemesis Syndrome 42

Nevada opens foster parenting to those with cannabis records 37

MediPharm Labs announces results of annual and special meeting, contradicting Apollo’s claims 34

New Hampshire Lawmakers Advance Psilocybin Penalty Reform But Reject Medical Marijuana Homegrow 8

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.